These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 7481623)
1. [Epidemiology of antibiotic resistance: implications for empirical treatment in intensive care]. Wolff M Schweiz Med Wochenschr; 1995 Sep; 125(36):1684-6. PubMed ID: 7481623 [TBL] [Abstract][Full Text] [Related]
2. Antibiotic use in neonatal sepsis. Yurdakök M Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468 [TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved? Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923 [TBL] [Abstract][Full Text] [Related]
4. The choice of empirical antibiotic therapy for nosocomial pneumonia. Ramirez JA J Chemother; 1994 Apr; 6 Suppl 2():47-50. PubMed ID: 7799054 [TBL] [Abstract][Full Text] [Related]
5. Impact of antibiotic-resistant bacteria on the outcome of ventilator-associated pneumonia. Combes A; Luyt CE; Trouillet JL Semin Respir Crit Care Med; 2006 Feb; 27(1):23-8. PubMed ID: 16508878 [TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. Feldman C J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171 [TBL] [Abstract][Full Text] [Related]
7. Microbiology and drug resistance mechanisms of fully resistant pathogens. Walsh FM; Amyes SG Curr Opin Microbiol; 2004 Oct; 7(5):439-44. PubMed ID: 15451497 [TBL] [Abstract][Full Text] [Related]
8. [Distribution of pathogen and resistance of nosocomial infections in the intensive care units]. Dai CM; Zhou JD; Wu Y; Qi Y Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):277-80. PubMed ID: 16706133 [TBL] [Abstract][Full Text] [Related]
9. Hospital-acquired pneumonia in critically ill patients: factors associated with episodes due to imipenem-resistant organisms. Leroy O; d'Escrivan T; Devos P; Dubreuil L; Kipnis E; Georges H Infection; 2005 Jun; 33(3):129-35. PubMed ID: 15940413 [TBL] [Abstract][Full Text] [Related]
17. Epidemiology of healthcare-associated pneumonia (HCAP). Zilberberg MD; Shorr AF Semin Respir Crit Care Med; 2009 Feb; 30(1):10-5. PubMed ID: 19199182 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia. Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563 [TBL] [Abstract][Full Text] [Related]
19. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response. Ciofu O APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154 [TBL] [Abstract][Full Text] [Related]